Better Buy: Amgen Inc. vs. Celgene Corp.

These two big biotechs are both attractively priced after the recent downturn in the sector. But which has the more compelling growth outlook?

Many biotech stocks have taken a beating since last August, and it hasn't just been smaller players feeling the pain. Shares of two of the biggest biotechs -- Amgen (NASDAQ:AMGN)and Celgene (NASDAQ:CELG) -- are down 15% and 23%, respectively. There's a good case to be made that both Amgen and Celgene present compelling opportunities for investors after these declines. But which is the better buy? Here are the arguments for each stock. 

So which biotech is the better investment pick?...


Source: The Motley Fool